Generic Trends





GPhA Lobbies for Fully Funded FDA and OGD 11/16/2011


Prasco Is Eli Lilly's Authorized Generic Partner 11/16/2011


Study: Generics Saved $931 Billion Over Past 10 Years 11/16/2011


Generic Docetaxel Approved 4/20/2011


Glenmark's Levocetirizine Dihydrochloride Approved 4/20/2011


Mylan Receives Approval for Generic Neurontin 4/20/2011


Pfizer and Aurobindo Sign Licensing Agreement 4/20/2011


Watson Announces Favorable Ruling in Fentora Suit 4/20/2011


Par Begins Shipping Generic Lotrel 2/18/2011

Spectrum to Develop Biosimilar Rituximab 2/18/2011

Watson's Generic Fentora Receives FDA Approval 2/18/2011

Perrigo and Synthon Announce Approval and Launch of Generic Xyzal 1/20/2011


Sagent Announces Approval of Midazolam Injection, USP 1/20/2011


Teva Files Petition Surrounding Generic Copaxone 1/20/2011


Watson and Natco in Agreement for Generic Revlimid 1/20/2011


CVS Supports Biogenerics Approval Pathway 12/17/2010


Exclusivity for Vyvanse Upheld 12/17/2010


Generic Mirapex Tablets Approved 12/17/2010


Paddock Introduces Antispasmodic/Antimuscarinic 12/17/2010


Watson to Distribute Generic Concerta 12/17/2010


For more articles, please check our archives.
Advertisement